Clinical Trial Update: A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating intratumoral INT230-6 versus US standard of care in adults with soft tissue sarcoma; the study is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• INT230-6

Snippet

Sponsor: Intensity Therapeutics, Inc. | Conditions: Sarcoma,Soft Tissue | Phase 3 | Status: ACTIVE_NOT_RECRUITING